Celadon Pharmaceuticals PLC (CEL) — Free Cash Flow Generation Index

Latest as of June 2020: -0.27x

Celadon Pharmaceuticals PLC (CEL) has a Free Cash Flow Generation Index of -0.27x as of June 2020. Free cash flow of GBX-30.05K represents 0% of operating cash flow (GBX109.70K). Explore Celadon Pharmaceuticals PLC (CEL) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-0.27x

Free Cash Flow / Operating CF

Free Cash Flow

GBX-30.05K

GBX

Operating Cash Flow

GBX109.70K

GBX

Capital Expenditures

GBX139.75K

GBX

Celadon Pharmaceuticals PLC Free Cash Flow Generation Index (2019–2019)

Historical FCF Generation Index trend for Celadon Pharmaceuticals PLC across 1 annual periods. For the full cash flow conversion analysis, see CEL operating cash flow.

Annual Free Cash Flow Generation for Celadon Pharmaceuticals PLC (2019–2019)

Year-by-year Free Cash Flow Generation Index for Celadon Pharmaceuticals PLC. Check total reinvestment intensity of Celadon Pharmaceuticals PLC to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (GBX)	Operating CF	Capital Expenditures	YoY Change
2019	1.00x	GBX1.98K	GBX1.98K	GBX0.00	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).